Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2006-05-19
2008-07-01
Gupta, Anish (Department: 1654)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C514S012200, C530S300000, C530S324000, C530S408000
Reexamination Certificate
active
07393828
ABSTRACT:
The invention relates to the field of drug delivery, in particular, to compounds and methods for the chemical modification of a proteinaceous channel to be used in pharmaceutical delivery vehicles for controlled and/or localized release of therapeutic molecules (e.g., small molecules, peptides, proteins or other macromolecules). Provided are pH- and/or light-responsive compounds capable of controlling the channel activity of a mechanosensitive channel, such as the MscL channel protein ofE. coli, or a functional equivalent thereof, and use of these compounds to convert a mechanosensitive channel protein into a pH- and/or light-responsive channel. Also provided are drug delivery vehicles comprising a pH- and/or light-responsive channel protein.
REFERENCES:
patent: WO 2005/051902 (2005-06-01), None
Medical Dictionary for different channels.
Yoshimura K, Batiza A, Kung C, Chemically Charging the Pore Constriction Opens the Mechanosensitive Channel MscL, Biophysical Journal, 2001, 80: 2198-2206.
Moe PC, Blount P, Kung C, Functional and structural conservation in the mechanosensitive channel MscL implicates elements crucial for mechanosensation, Molecular Microbiology, 1998, 28(3): 583-592.
Morton CC, Ion Channel Protein in Inner Ear Is Likely Long-sought Key to Hearing in FOCUS, Oct. 15, 2004.
Benach J, Hunt JF, Shape-shifting protein channel, Nature, 2004, 427: 24-26.
van den Berg B, Clemons WM, Collinson I, Modis Y, Hartman E, Harrison SC, Rapoport TA, X-ray structure of a protein-conducting channel, Nature, 2004, 427: 36-44.
Channel Structure Improves Understanding of Protein Transport in Howard Hughes Medical Institute Research News, Dec. 3, 2003.
Implications of Primary Structure in PPS96.
Luthy R, Bowie JU, Eisenberg D, Assessment of protein models with three-dimensional profiles, Nature, 1992, 356: 83-85.
Zhang H, Blake NW, Ouyang X, Pandolfino YA, Morgan-Capner P, Archard LC, A single amino acid substitution in the capsid protein VP1 of Coxsachievirus B3 (CVB3) alters plaque phenotype in Vero cells but not cardiovirulence in a mouse model, Archives of Virology, 1995, 140: 959-966.
Zhang YJ, Rutledge BJ, Rollins BJ, Structure/Activity Analysis of Human Monocyte Chemoattractant Protein-1 (MCP-1) by Mutagenesis, Journal of Biological Chemistry, 1994, 269(22): 15918-15924.
Scientists Identify a Protein Channel that Mediates the Body's Ability to Fell Frigid Temperatures, Mar. 4, 2003.
Batiza et al., “Gating the bacterial mechanosensitive channel MscL in vivo,” PNAS, Apr. 16, 2002, pp. 5643-5648, vol. 99, No. 8.
Yoshimura et al., “Chemically Charging the Pore Constriction Opens the Mechanosensitive Channel MscL,” Biophysical Journal, May 2001, pp. 2198-2206, vol. 80.
Kocer Armagan
Robillard George Thomas
Walko Martin
Applied NanoSystems B.V.
Gupta Anish
Ha Julie
TraskBritt
LandOfFree
Modified MscL protein channel does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Modified MscL protein channel, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Modified MscL protein channel will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3971664